These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 6168202

  • 1. Low-dose oral contraceptive usage and coagulation.
    Notelovitz M, Kitchens CS, Coone L, McKenzie L, Carter R.
    Am J Obstet Gynecol; 1981 Sep 01; 141(1):71-5. PubMed ID: 6168202
    [Abstract] [Full Text] [Related]

  • 2. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M, Kitchens CS, Khan FY.
    Am J Obstet Gynecol; 1992 Nov 01; 167(5):1255-61. PubMed ID: 1442974
    [Abstract] [Full Text] [Related]

  • 3. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S, Mishell DR, Gray G, Dozono-Takano R, Brenner PF, Eide I, de Quattro V, Shaw ST.
    Am J Obstet Gynecol; 1980 Apr 01; 136(7):920-31. PubMed ID: 6767404
    [Abstract] [Full Text] [Related]

  • 4. The effects of low-dose oral contraceptives on coagulation and fibrinolysis in two high-risk populations: young female smokers and older premenopausal women.
    Notelovitz M, Levenson I, McKenzie L, Lane D, Kitchens CS.
    Am J Obstet Gynecol; 1985 Aug 15; 152(8):995-1000. PubMed ID: 4025463
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.
    Petersen KR, Sidelmann J, Skouby SO, Jespersen J.
    Am J Obstet Gynecol; 1993 Jan 15; 168(1 Pt 1):32-8. PubMed ID: 8420344
    [Abstract] [Full Text] [Related]

  • 7. [Blood coagulation and fibrinolysis in women receiving estrogen, gestagen and estrogen-gestagen-contraceptives (author's transl)].
    Lechner K, Hartmann E, Schneider WH, Spona J, Matt K.
    Klin Wochenschr; 1976 May 01; 54(9):431-8. PubMed ID: 1271696
    [Abstract] [Full Text] [Related]

  • 8. Effects of low and high dose oral contraceptives on blood coagulation and thrombogenesis induced by vascular subendothelium exposed to flowing human blood.
    Inauen W, Stocker G, Haeberli A, Straub PW.
    Contraception; 1991 May 01; 43(5):435-46. PubMed ID: 1833126
    [Abstract] [Full Text] [Related]

  • 9. Studies on plasma coagulation and fibrinolysis during oral contraception of various types with special reference to cold activation of factor VII.
    Gjonnaess H, Fagerhol MK.
    Scand J Haematol; 1974 May 01; 12(3):232-40. PubMed ID: 4831827
    [Abstract] [Full Text] [Related]

  • 10. Effect on blood coagulation and fibrinolysis in women using norethisterone or a combination of ethinyloestradiol and quingestianol.
    Korsan-Bengtsen K, Larsson B.
    Gynecol Obstet Invest; 1978 May 01; 9(6):312-8. PubMed ID: 754993
    [Abstract] [Full Text] [Related]

  • 11. Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid.
    Jespersen J, Petersen KR, Skouby SO.
    Am J Obstet Gynecol; 1990 Jul 01; 163(1 Pt 2):396-403. PubMed ID: 2196812
    [Abstract] [Full Text] [Related]

  • 12. Hemostatic effects of smoking and oral contraceptive use.
    Fruzzetti F.
    Am J Obstet Gynecol; 1999 Jun 01; 180(6 Pt 2):S369-74. PubMed ID: 10368523
    [Abstract] [Full Text] [Related]

  • 13. Comparative studies of 30 micrograms ethinyl estradiol combined with gestodene and desogestrel on blood coagulation, fibrinolysis, and platelets.
    Daly L, Bonnar J.
    Am J Obstet Gynecol; 1990 Jul 01; 163(1 Pt 2):430-7. PubMed ID: 2142580
    [Abstract] [Full Text] [Related]

  • 14. Effects of oral contraceptives on blood coagulation. A review.
    Beller FK, Ebert C.
    Obstet Gynecol Surv; 1985 Jul 01; 40(7):425-36. PubMed ID: 3895067
    [Abstract] [Full Text] [Related]

  • 15. Oral contraceptives and antithrombin III: variations by dosage and ABO blood group.
    Burkman RT, Bell WR, Zacur HA, Kimball AW.
    Am J Obstet Gynecol; 1991 Jun 01; 164(6 Pt 1):1453-8; discussion 1458-60. PubMed ID: 2048592
    [Abstract] [Full Text] [Related]

  • 16. Progestational agents and blood coagulation. V. Changes induced by sequential oral contraceptive therapy.
    Mink IB, Courey NG, Niswander KR, Moore RH, Lillie MA, Ambrus JL.
    Am J Obstet Gynecol; 1974 Jun 01; 119(3):401-5. PubMed ID: 4275088
    [Abstract] [Full Text] [Related]

  • 17. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW, de la Peña A, Chenault CB, Cervantes A.
    Am J Obstet Gynecol; 1975 Jul 01; 122(5):625-36. PubMed ID: 1146928
    [Abstract] [Full Text] [Related]

  • 18. Changes in blood coagulation and fibrinolysis in women receiving oral contraceptives. Comparison between treated and untreated women in a longitudinal study.
    Ygge J, Brody S, Korsan-Bengtsen K, Nilsson L.
    Am J Obstet Gynecol; 1969 May 01; 104(1):87-98. PubMed ID: 4180662
    [Abstract] [Full Text] [Related]

  • 19. Coagulation effects of oral contraception.
    Bonnar J.
    Am J Obstet Gynecol; 1987 Oct 01; 157(4 Pt 2):1042-8. PubMed ID: 2960241
    [Abstract] [Full Text] [Related]

  • 20. Prospective study of carbohydrate metabolism in women using a triphasic oral contraceptive containing norethindrone and ethinyl estradiol for 3 months.
    Spellacy WN, Ellingson AB, Kotlik A, Tsibris JC.
    Am J Obstet Gynecol; 1988 Oct 01; 159(4):877-9. PubMed ID: 3052079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.